natgillin/translations-raw huggingface dataset:
Tabletterne gives to gange om dagen med eller uden mad, 2-3 måneder er som regel tilstrækkeligt til at kontrollere adfærden, selv om nogle hunde har behov for en længere behandling.
The tablets are given twice a day with or without food and usually 2 – 3 months is sufficient to control the condition although some dogs may need longer treatment.
Tabletterne har en diameter på 20 mm og en tykkelse på 6,5 mm.
The tablets have a 20 mm diameter and a thickness of 6.5 mm.
Tabletterne har ’ESL 200’ præget på den ene side og delekærv på den anden side.
The tablets have ‘ESL 200’engraved on one side and are scored on the other side.
Tabletterne har ’ESL 400’ præget på den ene side og delekærv på den anden side.
The tablets have ‘ESL 400’engraved on one side and are scored on the other side.
Tabletterne har ’ESL 600’ præget på den ene side og delekærv på den anden side, så tabletten kan deles i to lige store dele.
The tablets have ‘ESL 600’engraved on one side and are scored on the other side, enabling the tablets to be divided into equal halves.
Tabletterne har ’ESL 600’ præget på den ene side og delekærv på den anden side.
The tablets have ‘ESL 600’engraved on one side and are scored on the other side.
Tabletterne har ’ESL 800’ præget på den ene side og delekærv på den anden side, så tabletten kan deles i to lige store dele.
The tablets have ‘ESL 800’engraved on one side and are scored on the other side, enabling the tablets to be divided into equal halves.
Tabletterne har ’ESL 800’ præget på den ene side og delekærv på den anden side, så tabletten kan deles i to lige store dele.
The tablets have ‘ESL 800’engraved on one side and are scored on the other side.
Tabletterne indeholder lactose monohydrat og bør derfor ikke indgives til patienter med sjældne medfødte problemer med galactose intolerans, LAPP laktase-mangel eller glukose-galactose malabsorption.
The tablets contain lactose monohydrate and therefore should not be administered to patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption.
Tabletterne indeholder også følgende hjælpestoffer Saccharose
Tablets also contain the following ingredients Sucrose
Tabletterne indeholder også lactose .
The tablets also contain lactose.
Tabletterne indeholder også lactosemonohydrat.
The tablets also contain lactose monohydrate.
Tabletterne indeholder også Sunset Yellow (E110) som farvestof.
The tablets also contain Sunset Yellow (E110) as a colourant
Tabletterne indeholder Sunset Yellow (E110) som farvestof.
The tablets also contain Sunset Yellow (E110) as a colorant.
Tabletterne indgives én gang dagligt på samme tid hver dag i en dosis på 1 mg pr. kilo legemsvægt med et interval på 1-2 mg/kg hos hunde eller 1-2,4 mg/kg hos katte.
The tablets are given once a day at the same time every day, at a dose of 1 mg per kilogram body weight with a range of 1-2 mg/kg in dogs or 1-2.4 mg/kg in cats.
Tabletterne kan administreres sammen med eller uden foder, er tilsat smag og ædes villigt af de fleste hunde.
The veterinary medicinal product can be administered with or without food, are flavoured and are taken by most dogs voluntarily.
Tabletterne kan deles i to lige store dele.
The tablet can be divided into equal halves.
Tabletterne kan deles via delekærven på tabletten.
Tablets are breakable along the score line on the tablet.
Tabletterne kan gives med eller uden foder.
Tablets can be administered with or without food.
Tabletterne kan indgives direkte i munden eller i foderet.
Tablets can be given either directly into the mouth or with food.
Tabletterne kan indtages med eller uden mad.
The tablets may be taken with or without food.
Tabletterne kan indtages uafhængigt af måltider.
The film- coated tablets can be taken with or without food.
Tabletterne kan indtages uafhængigt af måltider.
The film-coated tablets can be taken with or without food.
Tabletterne kan tages med eller uden mad.
Telzir tablets can be taken with or without food.
Tabletterne kan tages med eller uden mad.
They can be taken with or without a meal.
Tabletterne kan tages sammen med eller uden et måltid uafhængigt af tidspunktet på dagen.
The tablets can be taken with or without a meal at any time of the day.
Tabletterne leveres i aluminium/aluminium blisterpakninger med 14, 28, 30, 50, 56, 60, 90, 98, 112, 180 tabletter.
The tablets are supplied in aluminium/aluminium blister packs of 14, 28, 30, 50, 56, 60, 90, 98 or 180 tablets.
Tabletterne leveres i aluminium/aluminium blisterpakninger med 14, 28, 30, 50, 56, 60, 90, 98, 112, 180 tabletter.
They are supplied in aluminium/aluminium blisters in packs of 14, 28, 30, 50, 56, 60, 90, 98, 112, 180, multipacks of 196 (2 packs of 98) tablets or in aluminium/aluminium perforated unit dose blisters in packs of 60 x 1 tablets.
Tabletterne leveres i aluminium/aluminium-blisterpakninger a 14, 28, 30, 50, 56, 84, 90, 98, 112 eller 196 tabletter eller 50 x 1 tabletter i perforerede aluminium/aluminium- enkeltdosisblisterpakninger.
The tablets are supplied in Aluminium/aluminium blister packs of 14, 28, 30, 50, 56, 84, 90, 98, 112 or 196 tablets or 50 x 1 tablets in Aluminium/aluminium perforated unit dose blisters.
Tabletterne leveres i aluminium/aluminium-blisterpakninger med enten 14, 28, 30, 50, 90 eller
The tablets are supplied in aluminium/aluminium blister packs containing either 14, 28, 30, 50, 90 or
Tabletterne leveres i blisterpakninger med 2, 4, 8 eller 12 tabletter.
The tablets are provided in blister packs containing 2, 4, 8, or 12 tablets.
Tabletterne leveres i blisterpakninger med 4, 8 eller 12 tabletter.
The tablets are provided in blister packs containing 4, 8, or 12 tablets.
Tabletterne leveres i PA/aluminium/PVC/aluminium-blisterpakninger, pakninger a 14, 28, 30, 50, 56, 90 og, 98 tabletter.
The tablets are supplied in PA/Aluminium/PVC/Aluminium blister packs of 14, 28, 30, 50, 56, 90 or 98 tablets.
Tabletterne leveres i PA/aluminium/PVC/aluminium-blisterpakninger, pakninger a 14, 28, 30, 50, 56, 90 og, 98 tabletter.
The tablets are supplied in PA/Aluminium/PVC/Aluminium blister packs of 14, 28, 30, 50, 56, 90 or 98tablets.
Tabletterne leveres i perforerede blisterpakninger i enhedsdoseringer, i æsker indeholdende 14, 28, 56 eller 98, 28 x 1 tabletter.
They are supplied in PA/Alu/PVC-Aluminium foil perforated blisters packed in cardboard box containing 14, 28, 56 or 98 tablets and 28 x 1 tablets (unit dose).
Tabletterne leveres i PVC/PVDC/Aluminiumsblisterpakninger med 14, 20, 28 eller 56 tabletter.
The tablets are supplied in PVC/PVDC/Aluminium blister packs of 14, 20, 28 or 56 tablets.
Tabletterne leveres i UPVC/monochlorotrifluorethylen-blisterpakninger med 28 tabletter.
The tablets are provided in UPVC/Monochlorotrifluorethylene blister packs containing 28 tablets.
Tabletterne med 3 mg og 4 mg indeholder også indigocarmin E132 og gul jernoxid E 172
The 3 mg and 4 mg tablets also contain indigo carmine E 132 and yellow iron oxide E 172
Tabletterne med 30 mg indeholder også: jernoxid, gul (E172) og jernoxid, sort (E172).
The 30 mg tablets also contain iron oxide yellow (E172) and iron oxide black(E172).
Tabletterne med modificeret udløsning er runde (diameter 8 mm) og konvekse.
The modified-release tablets are round (diameter 8 mm) and convex.
Tabletterne må hverken deles, knuses, opløses, suttes eller tygges.
Do not divide, crush, dissolve, suck or chew the tablet.
Tabletterne må ikke brækkes over eller knuses.
Do not break or crush the tablets.
Tabletterne må ikke deles eller knuses, da det påvirker optagelsen af Votrient og kan øge risikoen for bivirkninger.
Do not break or crush the tablets as it affects the way the medicine is absorbed and may increase the chance of side effects.
Tabletterne må ikke deles eller knuses.
The tablets must not be split or cut.
Tabletterne må ikke deles, knuses eller tygges.
Do not divide, crush or chew tablets.
Tabletterne må ikke deles, knuses eller tygges.
Do not split, crush or chew the tablets.
Tabletterne må ikke deles.
Do not break the tablets.
Tabletterne må ikke knuses eller deles
Do not break or crush tablet.
Tabletterne må ikke knuses eller tygges.
Do not crush or chew the tablet.
Tabletterne må ikke suttes, tygges eller knuses.
Do not suck, chew or crush the tablet.
Tabletterne må ikke tygges, deles eller knuses.
The tablets must not be chewed, broken or crushed.
Tabletterne må ikke tygges, knuses eller brækkes over.
Don’t chew, crush or split the tablet.
Tabletterne må ikke tygges, knuses eller deles på grund af forventede ændringer i den farmakokinetiske profil.
The tablets should not be chewed, crushed or split due to anticipated changes in the pharmacokinetic profile
Tabletterne må ikke tygges, knækkes eller opløses.
Do not chew, break, or dissolve the tablets.
Tabletterne må ikke tygges, suttes eller knuses.
Do not suck, chew or crush tablets.
Tabletterne må ikke tygges, suttes eller knuses.
Do not suck, chew or crush the tablets.
Tabletterne må kun gives, hvis barnet er i stand til at sluge tabletterne.
Tablets must only be given if the child is able to swallow tablets.
Tabletterne og den orale opløsning var bioækvivalente hos raske frivillige, og de to former kan derfor erstatte hinanden.
The tablet and oral solution were bioequivalent in healthy subjects; therefore, both forms may be used interchangeably.
Tabletterne opløses i et glas vand, inden patienten drikker opløsningen.
The tablets are dissolved in water before the patient drinks the solution.
Tabletterne på 0,5 mg og 2 mg indeholder også gul jernoxid og brun jernoxid.
The 0.5 mg and 2 mg tablets also contain yellow iron oxide and brown iron oxide.
Tabletterne skal altid tages med et glas vand og synkes hele.
Always take the tablet with water and swallow it whole.
Tabletterne skal altid tages, efter at patienten ikke har spist noget i mindst seks timer natten over, og mindst 30 minutter inden
The tablets must always be taken after the patient has not eaten anything for at least six hours overnight and at least 30 minutes before the
Tabletterne skal forblive i blisteret og opbevares i den ydre karton, indtil de skal bruges.
Keep tablets in the blister packs until required, and keep the blisters in the outer carton.
Tabletterne skal forblive i blisteret og opbevares i æsken, indtil de skal bruges.
Keep tablets in the blister packs until required, and keep the blisters in the outer carton.
Tabletterne skal indtages gennem munden og sluges hele med vand eller anden væske.
This medicine must be taken by mouth, swallowed whole with water or other liquids.
Tabletterne skal indtages oralt fordelt på tre doser hver dag.
The tablets must be taken in three divided doses each day.
Tabletterne skal indtages sammen med et helt glas
It should be taken with a full glass of plain water (in areas with hard water,
Tabletterne skal opbevares i den originale pakning indtil brug for at undgå, at børn får direkte adgang til lægemidlet.
The tablets should be kept in the original package until use in order to prevent children directly accessing the medicine.
Tabletterne skal sluges hele.
The tablets must be swallowed whole.
Tabletterne skal synkes hele med et glas postevand (180 til 240 ml), med patienten i siddende eller oprejst stilling.
The tablets should be swallowed whole with a full glass of water (180 to 240 ml) while the patient is standing or sitting in an upright position.
Tabletterne skal synkes hele med et glas vand (180 til 240 ml), mens patienten sidder ned eller står op.
Tablets should be swallowed whole with a glass of water (180 to 240 ml) while the patient is sitting or standing in an upright position.
Tabletterne skal synkes hele med et helt glas vand (180 til 240 ml), mens patienten står op eller sidder i oprejst stilling.
The tablets should be swallowed whole with a full glass of water (180 to 240 ml) while the patient is standing or sitting in an upright position.
Tabletterne skal synkes hele med et helt glas vand.
Take whole with a full glass of water.
Tabletterne skal synkes hele med vand.
Swallow Lamivudine/Zidovudine Teva tablets with some water.
Tabletterne skal synkes hele med vand.
The tablets should be swallowed whole with a drink of water.
Tabletterne skal synkes hele og må ikke knuses, tygges eller brækkes i stykker inden indgivelse.
Tablets should be swallowed intact and should not be crushed, chewed, or broken into pieces prior to administration.
Tabletterne skal synkes hele sammen med et glas vand.
Tablets should be swallowed without chewing with a glass of water.
Tabletterne skal synkes hele sammen med et halvt glas vand.
The tablets should be swallowed whole with half a glass of water.
Tabletterne skal synkes hele, og suspensionen skal tages senest 30 minutter efter tilberedning.
The tablets should be taken whole and the suspension should be taken within 30 minutes of being prepared.
Tabletterne skal synkes hele.
The tablets must be swallowed whole.
Tabletterne skal synkes med vand.
Swallow the tablet with some water.
Tabletterne skal tages gennem munden – med eller uden mad.
The tablets should be taken by mouth and can be taken with or without food.
Tabletterne skal tages hele og må ikke deles.
Tablets should be taken whole and not divided.
Tabletterne skal tages hele og må ikke deles.
The tablets must be taken whole and are not to be divided.
Tabletterne skal tages hele sammen med mad.
The tablets are taken with food.
Tabletterne skal tages ud af blisteren kort før indtagelse.
Tablets should be taken out of the blister shortly before administration (see section 6.6).
Tabletterne skal tages uden mad.
The tablets should be taken without food.
Tabletterne skal tygges og tages i forbindelse med måltider.
Tablets must be chewed and taken with meals.
Tabletterne synkes hele med et glas vand
Swallow the tablets whole with a glass of water,
Tabletterne synkes hele med vand.
These should be swallowed whole with water.
Tabletterne synkes hele sammen med et glas væske.
Swallow the tablets whole with a glass of liquid.
Tabletterne synkes hele.
Swallow the tablets whole.
Tabletterne tages to gange dagligt dag 1-5 og dag 8-12 i hver behandlingscyklus.
The tablets are taken twice a day on days 1 to 5 and days 8 to 12 of each treatment cycle.
Tabletterne udleveres i en plastbeholder med børnesikret lukke.
The tablets are provided in a plastic bottle with a child-resistant closure.
Tabletterne à 0,5 mg er hvide, runde og bikonvekse med facetterede kanter.
The 0.5 mg tablets are white, round and biconvex with bevelled edges.
Tabletternes filmovertræk indeholder polyvinylalkohol, titandioxid (E171), macrogol 3350, talcum (E553b) og gul jernoxid (E172, 100 mg tablet) eller rød jernoxid (E172, 500 mg tablet).
The tablet film-coating contains polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc (E553b) and iron oxide yellow (E172, for 100 mg tablet) or iron oxide red (E172, for 500 mg tablet).
Tabletternes virkning blev målt på baggrund af behovet for at modtage yderligere analgesisk behandling (smertelindring) til katte efter operationen.
The effectiveness of the tablets was measured based on the need to provide extra analgesic treatment (pain relief) to cats following surgery.
Tabletvoks: Carnauba voks (E903)
Tablet polishing: carnauba wax (E903)
Tabuleret oversigt over bivirkninger Meget almindelig (≥ 1/10) Almindelig (≥ 1/100 til < 1/10)
Tabulated summary of adverse reactions Very common (≥ 1/10)
Tabuleret resumé over bivirkninger
Tabulated summary of adverse reactions
TAC = docetaxel, doxorubicin og cyclophosphamid FAC = 5-fluorouracil, doxorubicin og cyclophosphamid CI = konfidensinterval; ER = østrogenreceptor
TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophosphamide CI = confidence interval; ER = estrogen receptor
TAC = docetaxel, doxorubicin og cyclophosphamid FAC = 5-fluoruracil, doxorubicin and cyclophosphamid
TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophospamide CI = confidence interval
TAC = docetaxel, doxorubicin og cyclophosphamid FAC = 5-fluoruracil, doxorubicin and cyclophosphamid
TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophospamide CI = confidence interval; ER = estrogen receptor
TAC = docetaxel, doxorubicin og cyclophosphamid FAC = 5-fluoruracil, doxorubicin and cyclophosphamid CI = Konfidensinterval; ER = østrogenreceptor
TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophospamide CI = confidence interval; ER = estrogen receptor
TAC = docetaxel, doxorubicin og cyclophosphamid FAC = 5-fluoruracil, doxorubicin og cyclophosphamid CI = Konfidensinterval; ER = østrogenreceptor
TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophosphamide CI = confidence interval; ER = estrogen receptor
TachoSil kan klippes/formes til en passende størrelse og facon.
TachoSil can be cut to the appropriate size and shaped to fit the wound.
TachoSil kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger.
Like all medicines, this medicine can cause side effects although not everybody gets them.
TachoSil leveres i en steril pakning og det er derfor vigtigt:
TachoSil comes in sterile packages and therefore it is important:
TachoSil, vævsklæbermatrix
TachoSil sealant matrix
TachoSils klæbende egenskaber kan - i lighed med andre præparaterr indeholdende thrombin - ødelægges, hvis matrixen udsættes for eller kommer i forbindelse med opløsninger, der indeholder alkohol, iod eller tungmetaller (for eksempel antiseptiske opløsninger).
Similar to comparable products or thrombin solutions, the sealant may be denatured after exposure to solutions containing alcohol, iodine or heavy metals (e.g. antiseptic solutions).
Tacrolimus
Antithrombotics
Tacrolimus (0,1 mg/kg
Tacrolimus (0.1 mg/kg single dose)
Tacrolimus (anvendes hos transplanterede patienter)
Tacrolimus (used in transplant patients)
Tacrolimus (anvendes ved organtransplantation)
Tacrolimus (in cases of organ transplantation)
Tacrolimus (bruges til transplanterede patienter)
Tacrolimus (used in transplant patients)
tacrolimus (for undertrykkelse af immunsystemet), non-steroide antiinflammatoriske midler (NSAID’er, til at lindre knogle- eller muskelsmerter).
tacrolimus (for suppression of the immune system), non-steroidal anti-inflammatory drugs (NSAIDs, to relieve bone or muscle pains).
Tacrolimus 0,03%
Tacrolimus 0.03
Tacrolimus 0,03% (N=189)
Tacrolimus 0.03% (N=189)
Tacrolimus 0,1% (N=186)
Tacrolimus 0.1% (N=186)
Tacrolimus 0,1% (N=487)
Tacrolimus 0.1% (N=487)
tacrolimus anbefales.
recommended.
tacrolimus AUC 0,83 (0,59-1,16)  tacrolimus Cmax 0,76 (0,65-0,90)  tacrolimus Cmin ikke undersøgt simeprevir AUC 1,85 (1,18-2,91) 6 simeprevir Cmax 1,79 (1,22-2,62) 6 simeprevir Cmin ikke undersøgt6
simeprevir AUC 1.85 (1.18-2.91) ↑6 simeprevir Cmax 1.79 (1.22-2.62) ↑6
tacrolimus AUC ↑ 1.610 %
with tacrolimus requires
Tacrolimus AUCt ↑ 221 %
Tacrolimus AUCt ↑ 221
tacrolimus Cmaks. ↑ 890 %
tacrolimus AUC ↑ 1610
Tacrolimus Cmax ↑ 117 %
Tacrolimus Cmax ↑ 117
tacrolimus eller sirolimus kan ikke
Lansoprazole
Tacrolimus er blevet anvendt siden midten af 1990’erne.
Tacrolimus has been used since the mid-1990’s.
Tacrolimus er et meget potent immunsuppressivt middel, der har vist aktivitet i både in vitro- og in vivo- undersøgelser.
Tacrolimus is a highly potent immunosuppressive agent and has proven activity in both in vitro and in vivo experiments.
Tacrolimus er siden midten af 1990'erne blevet anvendt til at mindske afstødningen hos transplantationspatienter (når immunsystemet angriber det transplanterede organ).
Tacrolimus has been used since the mid-1990’s to help prevent rejection in transplant patients (when the immune system attacks the transplanted organ).
Tacrolimus har været godkendt i Den Europæiske Union (EU) til forebyggelse af organafstødning siden midten af 1990’erne.
Tacrolimus has been available in the European Union (EU) for preventing organ rejection since the mid-1990’s.
Tacrolimus hæmmer kroppens forsvarsmekanisme (immunforsvar), som derefter ikke vil kunne bekæmpe infektioner så godt som normalt.
Tacrolimus reduces your body’s defence mechanism (immune system), which will not be as good at fighting infections.
Tacrolimus hæmmer T-celleaktivering og T-hjælpercelleafhængig B- celleproliferation, samt dannelsen af lymfokiner (såsom interleukin-2 og -3 og γ-interferon) og nedreguleringen af interleukin 2-receptorer.
Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.
Tacrolimus hæmmer T-celleaktivering og T-hjælpercelleafhængig B-celleproliferation samt dannelsen af lymfokiner (såsom interleukin-2 og -3 og -interferon) og ekspression af interleukin-2 receptoren.
Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.
Tacrolimus kan
Tacrolimus
tacrolimus kan blive påvirket
tacrolimus may be affected
Tacrolimus kan forlænge QT–intervallet og forårsage torsades de pointes.
Tacrolimus may prolong the QT interval and may cause Torsades de Pointes.
Tacrolimus kan forlænge QT–intervallet og forårsage torsades de pointes.
Tacrolimus may prolong the QT interval and maycause Torsades de Pointes.
Tacrolimus monohydrat
Tacrolimus monohydrate
tacrolimus og sirolimus (anvendes under og efter transplantationskirurgi)
tacrolimus and sirolimus (used during or after transplant surgery)
tacrolimus og sirolimus (anvendes under og efter transplanteringskirurgi)
tacrolimus and sirolimus (used during or after transplant surgery)
Tacrolimus og sirolimus (anvendt i transplanteringskirurgi)
Tacrolimus and sirolimus (used in transplant surgery)
Tacrolimus startede som kontinuerlig intravenøs infusion med doser på 0,05 mg/kg/dag, hvorefter oral tacrolimus blev administreret i doser på 0,1 – 0,3 mg/kg/dag med følgende dosisjustering for at nå dalkoncentrationer på 12 – 15 ng/ml.
Tacrolimus was started as continuous intravenous infusion at a dose of 0.05 mg/kg/day and oral tacrolimus was administered at a dose of 0.1 to 0.3 mg/kg/day with subsequent dose adjustments to target trough levels of 12 to 15 ng/ml.
tacrolimus til forebyggelse af afstødning af et transplanteret organ
tacrolimus to prevent organ transplant rejection
Tacrolimus undertrykker T-celleaktivering og T-hjælpecelle-afhængig B- celleproliferation samt dannelsen af lymfokiner (f.eks. interleukin-2, -3 og γ-interferon) og ekspressionen af interleukin-2-receptoren.
Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.
Tacrolimus virker på nogle særlige celler i immunsystemet, T-cellerne, som primært er ansvarlige for, at det transplanterede organ angribes (or- ganafstødning).
Tacrolimus acts on some special cells in the immune system called T-cells that are primarily responsible for attacking the transplanted organ (organ rejection).
Tacrolimus virkningsmekanisme i atopisk dermatitis er ikke fuldt klarlagt.
The mechanism of action of tacrolimus in atopic dermatitis is not fully understood.
Tacrolimus, det aktive stof i Protopy, er et immunmodulerende stof, dvs. det har indvirkning på immunsystemet (kroppens naturlige forsvar).
Tacrolimus, the active substance in Protopy, is an immunomodulator, this means that it works on the immune system (the body’s natural defences).
tacrolimus-dosis reduceres til en
dose be reduced to a third of the
tacrolimus-koncentrationer har
tacrolimus levels have been
tacrolimus-koncentrationerne
tacrolimus levels must be carefully
tacrolimus-relaterede
tacrolimus-related side
Tacrolimus/
IMMUNOSUPPRESSANTS
Tacrolimus/emtricitabin/ tenofovirdisoproxilfumarat (0,1 mg/kg q.d./200 mg/300 mg q.d.)
Tacrolimus/Emtricitabine/Tenofovir disoproxil fumarate (0.1 mg/kg q.d./200 mg/300 mg q.d.)
Tacrolimus/tenofovirdisoproxil /emtricitabin
Methadone/tenofovir disoproxil
Tacrolimus:
Methadone: